Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 1, 2025
A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention
Sara Vega-Abellaneda, Eva Román, Zaida Soler, et al.
Hepatology Communications
|
May 3, 2024
Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trial
Eva Román, Naujot Kaür, Elisabet Sánchez, et al.
Nutrients
|
January 25, 2025
Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
Raquel Diaz-Ruiz, Maria Poca, Eva Roman, et al.
Biomolecules
|
November 27, 2024
Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics
Luca Laghi, Maria Àngels Ortiz, Giacomo Rossi, et al.
JHEP Reports : Innovation in Hepatology
|
October 29, 2021
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
Ana Garcia Garcia de Paredes, Càndid Villanueva, Carolina Blanco, et al.
International Journal of Molecular Sciences
|
February 13, 2026
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
Albert Guinart-Cuadra, Anna Brujats, Justyna Szafranska, et al.
Journal of Clinical Medicine
|
November 13, 2021
Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis
Meritxell Ventura-Cots, Macarena Simón-Talero, Maria Poca, et al.
Hepatology (Baltimore, Md.)
|
February 22, 2023
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Oana Nicoară-Farcău, Juan J Lozano, Cristina Alonso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practice
Antonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
Liver International : Official Journal of the International Association for the Study of the Liver
|
November 1, 2025
A Metagenomics Approach to Frailty in Patients With Cirrhosis Undergoing a Multifactorial Intervention
Sara Vega-Abellaneda, Eva Román, Zaida Soler, et al.
Hepatology Communications
|
May 3, 2024
Home exercise, branched-chain amino acids, and probiotics improve frailty in cirrhosis: A randomized clinical trial
Eva Román, Naujot Kaür, Elisabet Sánchez, et al.
Nutrients
|
January 25, 2025
Vitamin D Supplementation Is Associated with Inflammation Amelioration and Cognitive Improvement in Decompensated Patients with Cirrhosis
Raquel Diaz-Ruiz, Maria Poca, Eva Roman, et al.
Biomolecules
|
November 27, 2024
Biomarkers of Frailty in Patients with Advanced Chronic Liver Disease Undergoing a Multifactorial Intervention Consisting of Home Exercise, Branched-Chain Amino Acids, and Probiotics
Luca Laghi, Maria Àngels Ortiz, Giacomo Rossi, et al.
JHEP Reports : Innovation in Hepatology
|
October 29, 2021
Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis
Ana Garcia Garcia de Paredes, Càndid Villanueva, Carolina Blanco, et al.
International Journal of Molecular Sciences
|
February 13, 2026
Immune and Endothelial-Related Extracellular Vesicles Are Associated with Corticosteroid Response and Mortality in Alcohol-Associated Hepatitis
Albert Guinart-Cuadra, Anna Brujats, Justyna Szafranska, et al.
Journal of Clinical Medicine
|
November 13, 2021
Effects of Albumin on Survival after a Hepatic Encephalopathy Episode: Randomized Double-Blind Trial and Meta-Analysis
Meritxell Ventura-Cots, Macarena Simón-Talero, Maria Poca, et al.
Hepatology (Baltimore, Md.)
|
February 22, 2023
Metabolomics as a tool to predict the risk of decompensation or liver-related death in patients with compensated cirrhosis
Oana Nicoară-Farcău, Juan J Lozano, Cristina Alonso, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 4, 2025
Defining non-invasive criteria for indicating drug therapy in metabolic-associated steatotic liver disease in clinical practice
Antonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, et al.
Journal of Gastroenterology
|
April 15, 2024
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, et al.
Page
of 5